Characteristics and antimicrobial choice of pediatric bacterial enteritis in the Kanto region of Japan: A multicenter retrospective observational study

J Infect Chemother. 2022 Jun;28(6):723-728. doi: 10.1016/j.jiac.2021.08.022. Epub 2022 Feb 26.

Abstract

Introduction: There are few reports on the causative microorganisms of bacterial enteritis in children in Japan in recent years. The distribution of causative microorganisms is important for estimating pathogens and making decisions regarding the treatment plan, as antimicrobial agents are not required for mild bacterial enteritis cases but are used for severe cases or immunocompromised patients.

Methods: We retrospectively surveyed pediatric patients who underwent stool culture at eight hospitals in the Kanto region of Japan from 2014 to 2019 for patient characteristics, causative microorganisms, and prescribed antimicrobial agents.

Results: A total of 4,475 stool cultures were submitted, and the positivity rate for bacterial enteritis was 11%. The causative microorganisms were Campylobacter spp. in 338 cases (67.3%), Salmonella spp. in 85 cases (16.9%), enterohemorrhagic Escherichia coli O157 in 23 cases (4.6%), and Yersinia spp. in 45 cases (9.0%). Hospitals with pediatric infectious disease physicians had a lower rate of antimicrobial therapy for Campylobacter enteritis than hospitals without pediatric infectious disease physicians.

Conclusions: Campylobacter spp. are the most common causative agent for bacterial enteritis in this study, and the presence of pediatric infectious disease physicians may promote the appropriate use of antimicrobial agents.

Keywords: Bacterial enteritis; Campylobacter; Enterohemorrhagic Escherichia coli; Fosfomycin; Salmonella.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents* / therapeutic use
  • Bacterial Infections* / drug therapy
  • Bacterial Infections* / epidemiology
  • Campylobacter Infections* / drug therapy
  • Campylobacter Infections* / epidemiology
  • Campylobacter*
  • Child
  • Communicable Diseases* / drug therapy
  • Enteritis* / drug therapy
  • Enteritis* / epidemiology
  • Humans
  • Japan / epidemiology
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents